Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

BCI (hydrochloride)

BCI ((E) -BCI) hydrochloride is a DUSP6 (dual specificity phosphatase 6) inhibitor. BCI hydrochloride shows anti-inflammatory activity and decreases reactive oxygen species (ROS) production. BCI hydrochloride can be used in inflammatory disease research[1][2].

Product Specifications

CAS Number

95130-23-7

Product Name Alternative

(E) -BCI (hydrochloride)

UNSPSC

12352005

Target

Phosphatase

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/e-z-bci-hydrochloride.html

Purity

99.93

Solubility

DMSO : 15.62 mg/mL (ultrasonic)

Smiles

O=C1/C(C(NC2CCCCC2)C3=C1C=CC=C3)=C/C4=CC=CC=C4.Cl

Molecular Formula

C22H24ClNO

Molecular Weight

353.89

References & Citations

[1]Korotchenko VN, et al. In vivo structure-activity relationship studies support allosteric targeting of a dual specificity phosphatase. Chembiochem. 2014 Jul 7;15 (10) :1436-45.|[2]Zhang F, et al. DUSP6 Inhibitor (E/Z) -BCI Hydrochloride Attenuates Lipopolysaccharide-Induced Inflammatory Responses in Murine Macrophage Cells via Activating the Nrf2 Signaling Axis and Inhibiting the NF-κB Pathway. Inflammation. 2019 Apr;42 (2) :672-681.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Citation 01

Cancer Med. 2024 Oct;13 (19) :e70276.|Cancers (Basel) . 2023 Sep 6;15 (18) :4442.|Cell Rep. 2025 Feb 20;44 (3) :115340.|Development. 2023 Mar 1;150 (5) :dev201090.|Phytother Res. 2023 Jul;37 (7) :2979-2994.|Transplant Proc. 2025 Aug 11:S0041-1345 (25) 00350-1.|University of Washington. 2025.|bioRxiv. 2024 Feb 5.|Cells. 2022 Feb 19;11 (4) :732.|Dis Model Mech. 2023 May 1;16 (5) :dmm049662.|FASEB J. 2025 Jul 15;39 (13) :e70780.|Int Immunopharmacol. 2024 Sep 30;143 (Pt 1) :113280.|J Nanobiotechnology. 2025 Jun 6;23 (1) :422.|Kaohsiung J Med Sci. 2023 Mar;39 (3) :254-265.|Neural Regen Res. 2023 Aug;18 (8) :1743-1749.|Sci Rep. 2025 May 24;15 (1) :18115.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

SIX4 (Sine Oculis Homeobox Homolog 4, Homeobox Protein SIX4, AREC3)
MBS647176-01 0.1 mg

SIX4 (Sine Oculis Homeobox Homolog 4, Homeobox Protein SIX4, AREC3)

Sign In for Pricing
View Details
SIX4 (Sine Oculis Homeobox Homolog 4, Homeobox Protein SIX4, AREC3)
MBS647176-02 5x 0.1 mg

SIX4 (Sine Oculis Homeobox Homolog 4, Homeobox Protein SIX4, AREC3)

Sign In for Pricing
View Details
LEPREL2 sgRNA CRISPR Lentivector set (Human)
K1208601 3x 1.0 µg

LEPREL2 sgRNA CRISPR Lentivector set (Human)

Sign In for Pricing
View Details
PLCXD1 Antibody, HRP conjugated
A70967-50UG 50 µg

PLCXD1 Antibody, HRP conjugated

Sign In for Pricing
View Details
TSEN34 Protein Vector (Mouse) (pPB-C-His)
PV242234 500 ng

TSEN34 Protein Vector (Mouse) (pPB-C-His)

Sign In for Pricing
View Details
TXNDC2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)
LV700560 1.0 µg DNA

TXNDC2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

Sign In for Pricing
View Details